Menu
Décideurs

De Gaulle Fleurance recognised in the 2026 Décideurs – Leaders League ranking for Healthcare, Pharma & Biotech

Awards 5 October 2026

The recognition spans eight distinct categories in the life sciences and healthcare sector, and reflects the depth of the firm’s expertise, from regulatory matters and strategic advisory work to litigation, intellectual property and transactions.

De Gaulle Fleurance ranked “Incontournable” in Regulatory Law

The firm’s regulatory practice, led by partners Frédéric Destal and Cécile Théard-Jallu, is ranked “Incontournable”, the highest level of recognition in this category. The distinction acknowledges the firm’s support for players in the pharmaceutical, medical device and biotechnology industries within a constantly evolving environment, at both French and European level.

Frédéric
Destal
Partner
Cécile
Théard-Jallu
Partner

De Gaulle Fleurance ranked “Incontournable” in Digital Health Law

The firm is also ranked “Incontournable” for its work on digital health, including artificial intelligence applied to care, connected medical devices and health data, a distinction embodied by Cécile Théard-Jallu. This recognition confirms De Gaulle Fleurance’s position at the intersection of healthcare law and emerging technologies.

Cécile
Théard-Jallu
Partner

De Gaulle Fleurance ranked “Excellent” in Patents, Pharma Litigation, Biotech and Life Sciences

The firm is rated “Excellent” for its support on licensing, co-development and research and development transactions, which are central to industrial partnerships in the pharmaceutical and biotech sectors. The distinction is shared by Francine Le Péchon-Joubert and Cécile Théard-Jallu.

francine-le-pechon-joubert
Francine
Le Péchon-Joubert
Partner
Cécile
Théard-Jallu
Partner

De Gaulle Fleurance ranked “Excellent” in Licensing, Co-development and R&D Agreements

De Gaulle Fleurance is rated “Excellent” for its support on licensing, co-development and research and development transactions, which are central to industrial partnerships in the pharmaceutical and biotech sectors. Once aigain, the distinction is shared by Francine Le Péchon-Joubert and Cécile Théard-Jallu.

francine-le-pechon-joubert
Francine
Le Péchon-Joubert
Partner
Cécile
Théard-Jallu
Partner

De Gaulle Fleurance ranked “Forte notoriété” in Equity Transactions, Joint Ventures and Corporate

De Gaulle Fleurance enjoys a “Forte notoriété” ranking for its work on equity transactions, minority investments and joint ventures in the life sciences sector, a distinction shared by partners Jean-Christophe Amy, François Couhadon and Mireille Mull-Jochem.

Jean-Christophe
Amy
Partner
François
Couhadon
Partner
Mireille
Mull-Jochem
Partner

De Gaulle Fleurance ranked “Forte notoriété” in Venture Capital

In venture capital, a segment particularly active in financing biotech and medtech companies, the firm also receives a “Forte notoriété” ranking. Jean-Christophe Amy and Henri-Nicolas Fleurance are singled out in this category.

Jean-Christophe
Amy
Partner
Henri-Nicolas
Fleurance
Partner

De Gaulle Fleurance ranked “Forte notoriété” in Competition and Distribution

De Gaulle Fleurance is recognised in competition and distribution law as applied to the healthcare sector, a ranking that notably acknowledges the expertise of Cécile Théard-Jallu and Thierry Titone.

Cécile
Théard-Jallu
Partner
Thierry
Titone
Partner

De Gaulle Fleurance ranked “Pratique Réputée” in Healthcare Criminal Law

De Gaulle Fleurance’s expertise in healthcare criminal law is recognised as a “Pratique Réputée”, led by partner Albane Lancrenon. The ranking illustrates the firm’s ability to advise on the compliance and criminal liability issues specific to the healthcare sector.

Albane
Lancrenon
Partner

These eight distinctions reflect the collective commitment of De Gaulle Fleurance’s partners and lawyers, and the recognition of their sectoral expertise in healthcare, pharmaceutical and biotechnology law by clients and peers alike.

Would you like to be kept up to date with the latest news on this topic?
Sign up to receive e-mails of new articles, events, analysis... on the subjects most relevant to you.
Create your customized watch

Receive news on the topics
that matter to you

Latest news

Deals 10 November 2026
De Gaulle Fleurance Advises Lenders on the Financing of Siparex Midcap’s Investment in Satys Electric
arrivée-christian-leroux
Firm Life 20 October 2026
Christian Le Roux joins De Gaulle Fleurance as Of Counsel, responsible for development strategy
Tuesday, November 3, 2026 – 5:00 PM (CET)
Events webinar
03/11/202617h00
Europrivacy : GDPR Certification Now Available to Organisations Outside the EU
Epopée Gestion Enervivo
Articles 13 October 2026
De Gaulle Fleurance Assists Épopée Gestion and Enervivo in Investing in the Creation of a Platform Dedicated to Biomethane